搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
BioSpace
7 小时
TIGITs Trend Upward After iTeos/GSK Present Positive Data at ESMO
After several high-profile failures, including BMS’ $1.5B breakup with Agenus, anti-TIGIT therapies are generating cautious ...
来自MSN
8 小时
Cancer, cardiovascular drugs likely to win Nobel Prize as week begins
Cancer research or cardiovascular drugs may claim the Nobel Prize in Medicine, set to be announced Monday. With global crises ...
AFP on MSN
8 小时
Cancer, cardiovascular drugs tipped for Nobel as prize week opens
Cancer research or drugs treating cardiovascular illnesses could win a Nobel Prize on Monday when a week of laureate ...
clinicaltrialsarena
11 小时
TiumBio doses first participant in Phase II trial of immuno-oncology drug
TiumBio is dedicated to the discovery and development of new treatments for rare and incurable diseases ... Ministry of Food ...
Psychology Today
1 天
Can High Prolactin Levels Increase Risk of Breast Cancer?
Prolactin is an important hormone in reproduction, pregnancy and childbirth. But could it also play a role in the development ...
2 天
Hidden pandemic of AMR poses challenge for modern medicine
Silent superbug pandemic in India causing havoc, lack of new antibiotics, focus on cancer drugs, market distortion explained.
2 天
Royal news – live: Kate Middleton’s touching conversation with cancer teen who has ...
Ashley Hansen has served as the couple’s global communications chief for two years during a particularly tumultuous period ...
2 天
Summit Therapeutics: Cancer Drug With Great Potential On 'Fast Track' To US Market
Summit Therapeutics Inc. may have a potential successor to Merck's Keytruda with strong clinical data from China, but awaits ...
News Medical
3 天
NIH supports research on non-opioid pain relief for oral cancer patients
The School of Dentistry at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) earned the first National Institutes of Health grant under its new Center for Pain ...
3 天
Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile
Absci Corporation's initiation of a phase 1 study using ABS-101 for the treatment of patients with IBD expected early 2025.
Cure Today
3 天
FDA Grants Priority Review to Enhertu for HER2-Low and -Ultralow Breast Cancer
The antibody-drug conjugate will be reviewed for the potential treatment of previously treated, unresectable or metastatic ...
Frontiers
3 天
Long Noncoding RNAs in Cancer
Long Noncoding RNAs (LncRNAs) are proven to be critical in cancer biology playing a significant role in tumor formation and ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈